|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:alternativeName
|
4-chloro-N-(2-dimethylaminoethyl)-N-methylbenzamide
4-chloro-N-(2-(dimethylamino)ethyl)-N-methylbenzamide
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:CASNumber
|
161639-34-7
|
|
gptkbp:drugClass
|
analgesic
benzodiazepine
|
|
gptkbp:hasDevelopedBy
|
NeuroSearch
|
|
gptkbp:hasDevelopedIn
|
gptkb:Denmark
|
|
gptkbp:hasInChIKey
|
gptkb:QJQJQJQJQJQJQJ-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C12H17ClN2O
|
|
gptkbp:hasRelatedCompound
|
gptkb:benzodiazepines
gptkb:clozapine
NS11394
NS9283
|
|
gptkbp:hasSMILES
|
CN(C)CCNC(=O)C1=CC=C(C=C1)Cl
|
|
gptkbp:hasTherapeuticUse
|
sedation
analgesia
anxiolysis
|
|
gptkbp:hasUNII
|
6Q1K1Q1Q1Q
|
|
gptkbp:hasYearOfDiscovery
|
1990s
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NS16004
|
|
gptkbp:legalStatus
|
uncontrolled
|
|
gptkbp:mechanismOfAction
|
GABAA receptor positive allosteric modulator
glycine receptor positive allosteric modulator
|
|
gptkbp:molecularWeight
|
240.73 g/mol
|
|
gptkbp:PubChem_CID
|
10498018
CHEMBL2103862
|
|
gptkbp:routeOfAdministration
|
oral
intraperitoneal
|
|
gptkbp:sideEffect
|
muscle relaxation
sedation
ataxia
memory impairment
|
|
gptkbp:bfsParent
|
gptkb:NT16000_series
|
|
gptkbp:bfsLayer
|
8
|